LGC Clinical Diagnostics at AMP Europe 2024
LGC Clinical Diagnostics are joining us in booth #5. They are global leaders in clinical genomic assay implementation and routine quality control. Our portfolio of Seraseq® somatic cancer products enables the promise of clinical genomics with the design and manufacture of patient-like reference materials for use in the development, validation, and implementation of molecular next-generation sequencing (NGS) assays that support clinical evaluation and management of cancer diseases. These clinically relevant reference materials cover the functional areas of:
o Solid Tumor Profiling
o Liquid Biopsy
o Hematological Malignancy
o Tumor Mutational Burden
.png?width=48&height=48&name=FINAL%20LGC%20NEW%20LOGO%20-%20cmyk_White%20(1).png "FINAL LGC NEW LOGO - cmyk_White (1)"){kind=small}